Role of oxidized low density lipoprotein in atherogenesis - PubMed (original) (raw)
Review
Role of oxidized low density lipoprotein in atherogenesis
J L Witztum et al. J Clin Invest. 1991 Dec.
Abstract
Evidence to support an important role of oxidative modification in mediating the atherogenicity of LDL continues to grow. New hypotheses suggest mechanisms by which Ox-LDL or products of Ox-LDL can affect many components of the atherogenic process, including vasomotor properties and thrombosis, as well as lesion initiation and progression itself. These ideas suggest new approaches, that in combination with lowering of plasma cholesterol, could lead to the prevention of atherosclerosis and its complications.
Similar articles
- Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
Napoli C. Napoli C. G Ital Cardiol. 1997 Dec;27(12):1302-14. G Ital Cardiol. 1997. PMID: 9470066 Review. - The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.
Nakajima K, Nakano T, Tanaka A. Nakajima K, et al. Clin Chim Acta. 2006 May;367(1-2):36-47. doi: 10.1016/j.cca.2005.12.013. Epub 2006 Jan 30. Clin Chim Acta. 2006. PMID: 16448638 Review. - [The significance of ixidized low density lipoprotein in atherosclerosis].
Hansen PR. Hansen PR. Ugeskr Laeger. 1996 May 6;158(19):2706-10. Ugeskr Laeger. 1996. PMID: 8744072 Review. Danish. - Role of oxidative modifications in atherosclerosis.
Stocker R, Keaney JF Jr. Stocker R, et al. Physiol Rev. 2004 Oct;84(4):1381-478. doi: 10.1152/physrev.00047.2003. Physiol Rev. 2004. PMID: 15383655 Review. - Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ, Guérin M, Bruckert E. Chapman MJ, et al. Eur Heart J. 1998 Feb;19 Suppl A:A24-30. Eur Heart J. 1998. PMID: 9519339 Review.
Cited by
- Paraoxonase activity and antibodies to oxidized-LDL in chronic renal failure patients on renal replacement therapy.
Krishnaswamy PR, Rao A, Murali W, Sudarshan Ballal H. Krishnaswamy PR, et al. Indian J Clin Biochem. 2006 Sep;21(2):173-6. doi: 10.1007/BF02912937. Indian J Clin Biochem. 2006. PMID: 23105639 Free PMC article. - Daily White kwao krua dietary supplement alleviates LDL oxidative susceptibility, plasma LDL level and improves vasculature in a hypercholesterolemia rabbit model.
Ratanachamnong P, Phivthong-Ngam L, Namchaiw P. Ratanachamnong P, et al. J Tradit Complement Med. 2020 May 12;10(5):496-503. doi: 10.1016/j.jtcme.2020.05.001. eCollection 2020 Sep. J Tradit Complement Med. 2020. PMID: 32953566 Free PMC article. - Prevention of oxidative DNA damage in inner organs and lymphocytes of rats by green tea extract.
Kager N, Ferk F, Kundi M, Wagner KH, Misík M, Knasmüller S. Kager N, et al. Eur J Nutr. 2010 Jun;49(4):227-34. doi: 10.1007/s00394-009-0068-0. Epub 2009 Oct 23. Eur J Nutr. 2010. PMID: 19851801 - A potential role for nuclear factor of activated T-cells in receptor tyrosine kinase and G-protein-coupled receptor agonist-induced cell proliferation.
Yellaturu CR, Ghosh SK, Rao RK, Jennings LK, Hassid A, Rao GN. Yellaturu CR, et al. Biochem J. 2002 Nov 15;368(Pt 1):183-90. doi: 10.1042/BJ20020347. Biochem J. 2002. PMID: 12188924 Free PMC article. - Oxidized LDL: diversity, patterns of recognition, and pathophysiology.
Levitan I, Volkov S, Subbaiah PV. Levitan I, et al. Antioxid Redox Signal. 2010 Jul 1;13(1):39-75. doi: 10.1089/ars.2009.2733. Antioxid Redox Signal. 2010. PMID: 19888833 Free PMC article. Review.
References
- J Clin Invest. 1991 Apr;87(4):1146-52 - PubMed
- Proc Natl Acad Sci U S A. 1981 Oct;78(10):6499-503 - PubMed
- Arterioscler Thromb. 1991 Jan-Feb;11(1):15-22 - PubMed
- J Clin Invest. 1991 Jan;87(1):90-9 - PubMed
- JAMA. 1990 Dec 19;264(23):3047-52 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources